Clinical Study
Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study
Table 3
Effect of valve repositioning and cerebral embolic protection use on acute stroke.
| Stroke ≤72 hr after TAVR | Valve repositioning | No repositioning | value | N = 313 | N = 683 |
| With CEP | n = 31 | n = 61 | 1.00 | All-stroke | 0.0% (0) | 1.7% (1) | No CEP | n = 282 | n = 622 | 0.81 | All-stroke | 2.8% (8) | 2.6% (16) |
|
|